Comparison 16. HALOPERIDOL vs COMBINATIONS: a. HALOPERIDOL + LEVOMEPROMAZINE.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Global outcome: 1. No overall improvement | 1 | 19 | Risk Ratio (M‐H, Fixed, 95% CI) | 8.18 [0.50, 133.66] |